Shaan Tainton

Providing strategy and market research services to Federal and independent government agencies to improve decision making related to new technological adoption, covering areas such as policy development, helping technology manufactures bring their technologies to maturity and commercial success, design of integrated programs to improve stakeholder engagement with a focus on innovation and building collaboration. Services focus on applying the best in market and behavioural science to achieve impact in complex, heavily regulated environments.

Climate Change

Australian Renewable Energy Agency (ARENA)

• Building performance framework and metrics to measure impact of ARENA's technology portfolios focused on emission reduction to support transition towards emissions targets set for 2030 and 2050.
• Implementing specific requirements of Enhanced Commonwealth Performance Framework, ensuring compliance with relevant government legislation and policies.
• Collaborating with business functions and external stakeholders (subject matter experts) to establish performance targets, creating Impact Monitoring and Evaluation plans for strategic technology areas such as Hydrogen, Solar and Large-scale Battery Storage.
• Redesigning more effective follow-up programs across technological portfolios teams to share knowledge and increase innovation potential.
• Enhancing communication between stakeholders with well-crafted reports and case studies highlighting key achievements and challenges in bringing new technologies to commercialisation.
• Fostering culture of continuous learning within ARENA through active participation in training sessions on monitoring and impact evaluation practices.

Human Health

Commonwealth Scientific and Industrial Research Organisation (CSIRO)

• Developing framework for technologically innovative companies in Australia (Diagnostic devices, Biosensors and Bioactive natural products) to address global societal challenge of Antimicrobial Resistance. Identifying new ways to supporting these companies progress in navigating commercialisation pathways relating to manufacturing, government policy and international partnerships and knowledge sharing.

Australian Government Department of Health

• Developed a new framework for creating a national R&D agenda to address the societal challenge of antimicrobial resistance. Primary focus on identifying needs, gaps in knowledge, mapping new technological opportunities with national and international stakeholders.
• Managed service providers, conducted large-scale project risk assessments, managed assessment process for selecting suppliers, negotiation of complex legal contracts with portfolio and legal teams.
• Consulted with Government, industry and international agencies relating to human, animal, environment, food and plant health such as Department of Agriculture, Water and Environment and Food Services Australia and New Zealand.
• Conducted key stakeholder mapping and stakeholder engagement plan for three large, highly complex projects:

(i) AMR Technologies: A Pricing and Reimbursement Study

(ii) Developing a National AMR R&D Agenda, aligning with Global Agenda

(iii) Building a Monitoring and Evaluation Framework for new technologies

Responsible for design and management of client consulting and research engagements with Federal government clients to inform communication strategies and guide policy development, leading data interpretation and statistical analysis to identify key insights for clients, their stakeholders and customers. Facilitating data activation and design thinking workshops to address client societal and business challenges. Developing and presenting story and data driven reports to senior government and policy makers.

Department of Foreign Affairs and Trade (DFAT) – Communicating Strategy for International Trade and Foreign Investment

• Department of Foreign Affairs and Trade commissioned Colmar Brunton to conduct market research into community attitudes towards international trade and foreign investment. Engagement enabled Australian Government to identify effective messages and channels for communication, building positive sentiment and engagement. Findings were presented to senior policy makers and Senior Executive in DFAT.

Treasury Communications and Strategic Positioning

• Organisational positioning and communication strategies related to gender balance, attraction strategy for graduates, stakeholder engagement and community perceptions. Mapping current and ideal future states to support internal and external communication development. Qualitative and quantitative research with wide ranges of cohorts including SES and Deputy Secretary of each group, business groups, community sector, academia, associations and peak bodies.

Expanded market presence of company through successful client acquisitions and key partnerships. Areas of expertise include strategic positioning, segmentation, patient journey mapping, digital engagement, stakeholder and employee engagement, training needs analysis and new service/product innovation.

Employees Mutual : Health Care Behavioural Economics

• Research with health insurer agents, allied health professionals, government agencies and patients (injured workers) to improve return to work outcomes. This study enabled identification of solutions (digital and non-digital) to increase patient engagement on their journey to wellness. Research included quantitative and qualitative methods of data collection and workshops with case workers which identified behavioural economic interventions to reduce risk (of patients delaying their return to work) and improving engagement throughout the patient journey.

AstraZeneca plc

TAGRISSO

• Advanced EGFRm NSCLC research to identify changes in treatment alorythms with Oncologists.
• Advanced EGFRm NSCLC (Stage 3) patient journey mapping and mapping of treatment algorithms with Oncologists, Radiation Oncologists, Respiratory Physicians and Thoracic Surgeons.

Gilead Sciences Inc

• BICTARVY
• HIV Treatment Study and Switching Behaviour with Sexual Health Physicians and Infectious Disease Physicians.

AstraZeneca plc

• DURVALUMAB
• Inoperable Locally Advanced or Metastatic Urothelial Bladder Cancer Patient Journey Research with Medical Oncologists & Urologists.

Responsible for managing Ipsos Business Consulting Group, helping clients better understand underlying market dynamics to enable them to compete and grow in new markets.

• Services focus on providing marketing research to key sectors in Asian and Australia (Pharmaceutical/Health care/Technology/Energy sectors).
• Key solution areas included helping companies realign their business strategies with changing market conditions, assessing current and emerging threats, competitive and business intelligence, strategic positioning, sales team optimisation, go-to-market strategy, brand engagement, feasibility testing of new services / product offerings and channel optimisation (digital integration).
  
  

Building company strategy and brand as a provider of international market research and strategy services.
Management of company capital.
Business development primarily in B2B, Technology and Pharmaceutical/Healthcare sectors.

• Developed client base: Pfizer, Organon, Roche, Aventis, Rolls-Royce, IBM, Microsoft, HSBC Bank, Citi Bank, L'Oreal Paris, FBI, Global One, Verizon and Sprint.
  
• Multi-country research project design and management, analytics and results presentations, workshop facilitation for data activation.
• Established strategic partnerships with market research providers and independent specialist recruiters, moderators, simultaneous translators in France, Germany, UK, Japan, China, Mexico and Brazil to expand research capabilities.
• Significant technology related experience. Over 30 international projects with IBM (software as services, data storage, communication and collaboration technologies, grid computing and cloud computing).
• Awarded IBM Preferred Strategic Partner.
• Experience areas: strategic positioning, segmentation, brand attitudes, channel strategies, communication testing, new product testing, web-usability and pricing elasticity research.
• Web-based Product Development: Developed on-line viewing lounge for client observation of qualitative research studies internationally for Pharma and IT clients to foster collaboration. Clients could view research in local language or English via simultaneous translators.
• Over 30 strategic marketing studies conducted internationally for IBM.
• Over 20 strategic marketing studies with Pharmaceuticals and Medical Device Manufacturers (all multi-country)
  

Examples of Work

Green Oil Company / US Department of Defense

Biofuels Adoption Transportation and Logistics

• Enabled producer of biofuels in USA to explore senior decision-making structures in commercial and government sectors, identifying barriers and levers to facilitate switching behaviour (fossil fuels to biofuels).
  

Rolls-Royce: Designer, manufacturer and distributor of power systems for aviation and other industries

Employee Engagement Measurement System across 9 Countries.

Built measurement framework to assess employee engagement of Rolls-Royce (13,000 employees globally). Purpose of building this framework was to provide an ongoing system for benchmarking, monitoring and performance improvement. One outcome from this work was establishing of a system optimized across diverse lines of business and geography which engaged senior and mid-levels managers to take ownership for innovation, sharing cross-cultural thinking and achieving performance improvement. Once implemented it was actioned every 18 months / multiple years. All action planning was facilitated in person in local countries.

Design, implementation and analysis of global marketing research projects in Pharmaceutical / Health technology / B2B sectors. Responsibilities included end to end project management of global research programs, analysis and presentations. Responsibilities also included business development, proposal writing and facilitation of creative workshops to assist clients in utilising findings.

Pharmaceutical Treatment Areas: Alzheimer's Disease, Dermatology, Congestive Heart Failure, Obsessive Compulsive Disorder, Schizophrenia and Diabetes (Type 1 and 2). Many research projects with GPs, Nurse Practitioners, Nurses, Medical Thought leaders, Specialists and patients in US, South America, Europe and Asia.

• Abbott Laboratories - Infant nutrition (Similac) EMEA Research with mothers
• Roche - Isotretinoin (Accutane) EMEA, LATAM, America Research with Dermatologists
• Becton Dickinson - (Various Devices for Diabetes) EMEA, America Research Patients, Caregivers and Nurse Practitioners
• Pfizer - Atorvastatin (Lipitor) EMEA, APAC, LATAM Research with Primary Card Doctors, Cardiologists and Endocrinologists)

• Designed and implemented customer, employee and stakeholder engagement systems for large, multinational commercial companies and government departments. Responsible for account management and business development, including full cycle project management of customer, employee and stakeholder research projects conducted within US and internationally.
• Activities included facilitating workshops in local countries and at headquarters, design of sampling plans, conducting focus groups and executive interviews, design of web research projects, analysis of results (including linking of employee and customer attitudes with bottom-line business performance measures through multivariate methods), presentation of results to senior executive teams and executive boards.